Business · 20/06/2013

FDA Releases Guidance on Stability Testing for Generic Drug Manufacturers

The Food and Drug Administration (FDA) has made available a guidance document recommending generic drug manufacturers follow International Conference on Harmonisation (ICH) guidelines for stability testing of drug substances and products, aiming to standardize stability testing policies and streamline the abbreviated new drug application (ANDA) review process.